1-8 of 8
Philip A. Thompson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Ending endless follow-up for low-risk CLL?

Philip A. Thompson
Journal: Blood Advances
Blood Adv (2024) 8 (16): 4447–4448.
https://doi.org/10.1182/bloodadvances.2024012918
Published: 2024
Journal Articles

A multicenter study of venetoclax-based treatment for patients with Richter transformation of chronic lymphocytic leukemia

Clinical Trials & Observations
Paul J. Hampel, Mahesh Swaminathan, Kerry A. Rogers, Erin M. Parry, Jan A. Burger, Matthew S. Davids, Wei Ding, Alessandra Ferrajoli, Jonathan M. Hyak, Nitin Jain, Saad S. Kenderian, Yucai Wang, William G. Wierda, Jennifer A. Woyach, Sameer A. Parikh, Philip A. Thompson
Journal: Blood Advances
Blood Adv (2024) 8 (10): 2342–2350.
https://doi.org/10.1182/bloodadvances.2023012080
Published: 2024
Includes: Supplemental data
Journal Articles

BTK inhibitors in CLL: second-generation drugs and beyond

Constantine Tam, Philip A. Thompson
Journal: Blood Advances
Blood Adv (2024) 8 (9): 2300–2309.
https://doi.org/10.1182/bloodadvances.2023012221
Published: 2024
Journal Articles

Venetoclax-rituximab is active in patients with BTKi-exposed CLL, but durable treatment-free remissions are uncommon

Thomas E. Lew, Rory Bennett, Victor S. Lin, Ashley Whitechurch, Sasanka M. Handunnetti, Paula Marlton, Yandong Shen, Stephen P. Mulligan, Joshua Casan, Piers Blombery, Constantine S. Tam, Andrew W. Roberts, John F. Seymour, Philip A. Thompson, Mary A. Anderson
Journal: Blood Advances
Blood Adv (2024) 8 (6): 1439–1443.
https://doi.org/10.1182/bloodadvances.2023011327
Published: 2024
Includes: Supplemental data
Journal Articles

Outcomes of breakthrough COVID-19 infections in patients with hematologic malignancies

Kelly S. Chien, Christine B. Peterson, Elliana Young, Dai Chihara, Elizabet E. Manasanch, Jeremy L. Ramdial, Philip A. Thompson
Journal: Blood Advances
Blood Adv (2023) 7 (19): 5691–5697.
https://doi.org/10.1182/bloodadvances.2022008827
Published: 2023
Journal Articles

Diminished humoral and cellular responses to SARS-CoV-2 vaccines in patients with chronic lymphocytic leukemia

Clinical Trials & Observations
Chaitra Ujjani, Ted A. Gooley, Stephen E. Spurgeon, Deborah M. Stephens, Catherine Lai, Catherine M. Broome, Susan O’Brien, Haiying Zhu, Kerry J. Laing, Allison M. Winter, Georgios Pongas, Alexander L Greninger, David M. Koelle, Tanya Siddiqi, Matthew S. Davids, Kerry A. Rogers, Alexey V. Danilov, Amy Sperling, Brian Tu, Tyler Sorensen, Kelsey Launchbury, Carlissa J. Burrow, Genesis Quezada, Joshua A. Hill, Mazyar Shadman, Philip A. Thompson
Journal: Blood Advances
Blood Adv (2023) 7 (17): 4728–4737.
https://doi.org/10.1182/bloodadvances.2022009164
Published: 2023
Includes: Supplemental data
Journal Articles

Prognostic value of measurable residual disease after venetoclax and decitabine in acute myeloid leukemia

Clinical Trials & Observations
Abhishek Maiti, Courtney D. DiNardo, Sa A. Wang, Jeffrey Jorgensen, Tapan M. Kadia, Naval G. Daver, Nicholas J. Short, Musa Yilmaz, Naveen Pemmaraju, Gautam Borthakur, Prithviraj Bose, Ghayas C. Issa, Alessandra Ferrajoli, Elias J. Jabbour, Nitin Jain, Guillermo Garcia-Manero, Maro Ohanian, Koichi Takahashi, Guillermo Montalban-Bravo, Lucia Masarova, Jan A. Burger, Philip A. Thompson, Srdan Verstovsek, Koji Sasaki, Michael Andreeff, Caitlin R. Rausch, Kathryn S. Montalbano, Sherry Pierce, Wei Qiao, Jing Ning, Hagop M. Kantarjian, Marina Y. Konopleva, Farhad Ravandi
Journal: Blood Advances
Blood Adv (2021) 5 (7): 1876–1883.
https://doi.org/10.1182/bloodadvances.2020003717
Published: 2021
Includes: Supplemental data
Journal Articles

Efficacy and predictors of response of lenalidomide and rituximab in patients with treatment-naive and relapsed CLL

Clinical Trials & Observations
Paolo Strati, Koichi Takahashi, Christine B. Peterson, Michael J. Keating, Philip A. Thompson, Naval G. Daver, Nitin Jain, Jan A. Burger, Zeev Estrov, Susan M. O'Brien, Hagop M. Kantarjian, William G. Wierda, P. Andrew Futreal, Alessandra Ferrajoli
Journal: Blood Advances
Blood Adv (2019) 3 (9): 1533–1539.
https://doi.org/10.1182/bloodadvances.2019031336
Published: 2019